Wendy's just said no to one of Wall Street's most famous corporate raiders — and it swallowed a poison pill to prove it means it.
The US burger chain has rejected a $1.4 billion takeover proposal from an investor group led by billionaire Nelson Peltz, arguing the $7.35-per-share cash offer significantly undervalues the company and its turnaround prospects.
The poison pill defence
Alongside the rejection, Wendy's board adopted a one-year shareholder rights plan on November 4. The "poison pill" kicks in if any investor crosses 15% ownership without board approval, letting other shareholders buy stock at a discount and diluting the raider's stake. The plan runs until November 3, 2027. It matters because Peltz's group — Trian Fund Management, Flynn Group, BlueFive Capital and Sixth Street Partners — already owns about 16.3% of Wendy's, and the group reportedly turned down a standstill agreement.
A burger chain under pressure
The fight comes as Wendy's battles falling sales and rising costs. The chain closed 240 restaurants in 2024 and plans to shut as many as 358 more in 2026. Same-store sales fell 5.2% last quarter, though revenue of $547 million beat expectations. New CEO Bob Wright — the fourth chief executive since 2024 — is betting on a turnaround plan called "Dave's Way," built on better food, sharper marketing and simpler operations.
Peltz knows this kitchen well
This is no stranger at the door. Peltz chaired Wendy's board for 17 years before stepping down in 2024, and his son Bradley still sits on the board. Peltz explored taking the chain private in 2022 before backing off. Now, with the chain on the ropes, the billionaire is back — and Wendy's has slammed the door.
Source: The Times of India, November 6, 2026. Image: AI-generated stylized illustration.